Based on the fact that leptin can enter the brain by crossing the blood–brain barrier [20], the novelty of the study is to investigate whether intraperitoneal injection of leptin has a neuroprotective effect on the AD mouse model, and to further explore the underlying mechanisms of the neuroprotective effect of leptin in AD. Here, LEP is linked to Alzheimer disease.